QA: Theriva Biologics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000894158_2023_Theriva_Biologics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000894158, Theriva Biologics Inc

  xvar xval
0 AssetsCurrent 45,520,000
1 IntangibleAssetsNetIncludingGoodwill 24,675,000
2 PropertyPlantAndEquipmentNet 345,000
3 remainder_Assets 1,321,000
4 LiabilitiesCurrent 7,060,000
5 LiabilitiesNoncurrent 1,187,000
6 remainder_Liabilities 9,050,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,000,476
9 ResearchAndDevelopmentExpense 14,417,362
10 remainder_Expenses -1,425,000
11 remainder_Revenues 0
12 remainder_NetIncome 405,006
13 remainder_ComprehensiveNetIncome -679,000
  yvar yval
0 Assets 71,861,000
1 Liabilities 17,297,000
2 Expenses 24,992,838
3 Revenues 0
4 StockholdersEquity 54,564,000
5 NetIncome -24,587,832
6 ComprehensiveNetIncome -24,927,332
7 BaseVar 57,617,422
8 EconomicCapitalRatiobeforeLimitedLiability 2.11
9 EconomicCapitalRatio 3.10

Edgar->Model Mapping

Feature Distribution

Change over Time